Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression.

Wang H, Mao XY, Zhao TT, Zheng XY, Jin F, Li JG.

Tumour Biol. 2012 Dec;33(6):1943-50. doi: 10.1007/s13277-012-0455-7. Epub 2012 Jul 14.

PMID:
22797820
2.

Clinicopathological characteristics of breast cancers with axillary skip metastases.

Sun J, Yin J, Ning L, Liu J, Liu H, Gu L, Fu L.

J Invest Surg. 2012 Feb;25(1):33-6. doi: 10.3109/08941939.2011.598605.

PMID:
22272635
3.

Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.

Yang C, Liu F, Li S, Li W, Zhai L, Ren M, Li Y, Lang R, Fan Y, Zhang X, Fu L.

Int J Surg Pathol. 2012 Dec;20(6):546-54. doi: 10.1177/1066896912451323. Epub 2012 Jun 25.

PMID:
22736300
4.

Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.

Bezić J, Samija-Projić I, Projić P, Ljubković J, Capkun V, Tomić S.

Pathol Res Pract. 2011 Jul 15;207(7):438-42. doi: 10.1016/j.prp.2011.04.005. Epub 2011 Jun 20.

PMID:
21689895
5.

[Axillary skip metastases in breast cancer].

Sun JY, Ning LS.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):352-5. Chinese.

PMID:
18953834
6.

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.

Breast Cancer Res Treat. 2007 Mar;101(3):279-84. Epub 2006 Jul 12.

PMID:
16835704
7.

Complete axillary lymph node dissection for stage I-II carcinoma of the breast.

Danforth DN Jr, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo T, Gorrell CR, Gerber NL, Lichter AS, Rosenberg SA, et al.

J Clin Oncol. 1986 May;4(5):655-62.

PMID:
3701387
8.

False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.

Park SH, Kim EK, Park BW, Kim SI, Moon HJ, Kim MJ.

Ultraschall Med. 2013 Dec;34(6):559-67. doi: 10.1055/s-0032-1313113. Epub 2012 Dec 20.

PMID:
23258771
9.

Microinvasive breast carcinoma with extensive involvement of level III axillary lymph nodes: a case report.

Fujii K, Fukutomi T, Tsuda H, Akashi-Tanaka S, Nanasawa T, Kanai Y, Muramatsu Y.

Jpn J Clin Oncol. 1998 Jan;28(1):47-9.

10.

Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients.

Vandorpe T, Smeets A, Van Calster B, Van Hoorde K, Leunen K, Amant F, Moerman P, Deraedt K, Brouckaert O, Van Huffel S, Wildiers H, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2011 Jul;128(2):429-35. doi: 10.1007/s10549-011-1565-4. Epub 2011 May 12.

PMID:
21562708
11.

Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?

Chua B, Ung O, Taylor R, Boyages J.

ANZ J Surg. 2002 Nov;72(11):786-92.

PMID:
12437688
12.

The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.

Yu J, Li G, Li J, Wang Y.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):874-8.

PMID:
15708269
13.

Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.

Durak MG, Akansu B, Akin MM, Sevınç AI, Koçdor MA, Saydam S, Harmancioğlu O, Ellıdokuz H, Bekış R, Canda T.

Turk Patoloji Derg. 2011;27(3):189-95. doi: 10.5146/tjpath.2011.01074.

14.

Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA.

Eur J Surg Oncol. 2002 Aug;28(5):481-9.

PMID:
12217299
15.

CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.

Looi LM, Cheah PL, Zhao W, Ng MH, Yip CH.

Malays J Pathol. 2006 Dec;28(2):83-6.

16.

[Clinical features and prognosis analysis of different breast cancer molecular subtypes].

Yang Q, Chen J, Li HJ, Yu M, Tian CX, Lü Q.

Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):42-6. Chinese.

PMID:
21575463
17.

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.

Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 Jan;113(1):181-7. doi: 10.1007/s10549-008-9914-7. Epub 2008 Feb 9.

PMID:
18264760
18.
19.
20.

Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy.

Kuru B, Camlibel M, Dinc S, Gulcelik MA, Alagol H.

Eur J Surg Oncol. 2003 Dec;29(10):839-44.

PMID:
14624774
Items per page

Supplemental Content

Write to the Help Desk